4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride

C153H220Cl4F6N18O39S7 — CID 162182654

IUPAC4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride
SMILESCCCCCC/C=C/C1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCCCCOC1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.CCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.Cl.Cl.Cl.Cl.O=C(NO)C1(S(=O)(=O)N2CCC(COCc3ccc(OC(F)(F)F)cc3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(-c4ccc(C(F)(F)F)cc4)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OCc4ccccc4)cn3)CC2)CCOCC1
InChIInChI=1S/C26H35N3O5S.C24H31N3O5S.C23H26F3N3O5S.C23H29N3O6S.C20H27F3N2O7S.C19H34N2O5S.C18H34N2O6S.4ClH/c1-2-3-4-20-5-7-21(8-6-20)23-9-10-24(27-19-23)22-11-15-29(16-12-22)35(32,33)26(25(30)28-31)13-17-34-18-14-26;1-2-18-3-5-19(6-4-18)21-7-8-22(25-17-21)20-9-13-27(14-10-20)33(30,31)24(23(28)26-29)11-15-32-16-12-24;24-23(25,26)19-4-1-16(2-5-19)18-3-6-20(27-15-18)17-7-11-29(12-8-17)35(32,33)22(21(30)28-31)9-13-34-14-10-22;27-22(25-28)23(10-14-31-15-11-23)33(29,30)26-12-8-19(9-13-26)21-7-6-20(16-24-21)32-17-18-4-2-1-3-5-18;21-20(22,23)32-17-3-1-15(2-4-17)13-31-14-16-5-9-25(10-6-16)33(28,29)19(18(26)24-27)7-11-30-12-8-19;1-2-3-4-5-6-7-8-17-9-13-21(14-10-17)27(24,25)19(18(22)20-23)11-15-26-16-12-19;1-2-3-4-5-6-13-26-16-7-11-20(12-8-16)27(23,24)18(17(21)19-22)9-14-25-15-10-18;;;;/h5-10,19,22,31H,2-4,11-18H2,1H3,(H,28,30);3-8,17,20,29H,2,9-16H2,1H3,(H,26,28);1-6,15,17,31H,7-14H2,(H,28,30);1-7,16,19,28H,8-15,17H2,(H,25,27);1-4,16,27H,5-14H2,(H,24,26);7-8,17,23H,2-6,9-16H2,1H3,(H,20,22);16,22H,2-15H2,1H3,(H,19,21);4*1H/b;;;;;8-7+;;;;;
InChIKeyHNMQRBWGIBLSGP-QFQGCDLXSA-N
MW3415.80 g/mol
LogP20.40
Rot. Bonds53

About 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride

4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride (PubChem CID 162182654) has the molecular formula C153H220Cl4F6N18O39S7 and a molecular weight of 3415.80 g/mol. Its IUPAC name is 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride.

Molecular Properties

Compound Name4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride
PubChem CID162182654
Molecular FormulaC153H220Cl4F6N18O39S7
Molecular Weight3415.80 g/mol
Exact Mass3411.25
IUPAC Name4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride
SMILESCCCCCC/C=C/C1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCCCCOC1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.CCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.Cl.Cl.Cl.Cl.O=C(NO)C1(S(=O)(=O)N2CCC(COCc3ccc(OC(F)(F)F)cc3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(-c4ccc(C(F)(F)F)cc4)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OCc4ccccc4)cn3)CC2)CCOCC1
InChIInChI=1S/C26H35N3O5S.C24H31N3O5S.C23H26F3N3O5S.C23H29N3O6S.C20H27F3N2O7S.C19H34N2O5S.C18H34N2O6S.4ClH/c1-2-3-4-20-5-7-21(8-6-20)23-9-10-24(27-19-23)22-11-15-29(16-12-22)35(32,33)26(25(30)28-31)13-17-34-18-14-26;1-2-18-3-5-19(6-4-18)21-7-8-22(25-17-21)20-9-13-27(14-10-20)33(30,31)24(23(28)26-29)11-15-32-16-12-24;24-23(25,26)19-4-1-16(2-5-19)18-3-6-20(27-15-18)17-7-11-29(12-8-17)35(32,33)22(21(30)28-31)9-13-34-14-10-22;27-22(25-28)23(10-14-31-15-11-23)33(29,30)26-12-8-19(9-13-26)21-7-6-20(16-24-21)32-17-18-4-2-1-3-5-18;21-20(22,23)32-17-3-1-15(2-4-17)13-31-14-16-5-9-25(10-6-16)33(28,29)19(18(26)24-27)7-11-30-12-8-19;1-2-3-4-5-6-7-8-17-9-13-21(14-10-17)27(24,25)19(18(22)20-23)11-15-26-16-12-19;1-2-3-4-5-6-13-26-16-7-11-20(12-8-16)27(23,24)18(17(21)19-22)9-14-25-15-10-18;;;;/h5-10,19,22,31H,2-4,11-18H2,1H3,(H,28,30);3-8,17,20,29H,2,9-16H2,1H3,(H,26,28);1-6,15,17,31H,7-14H2,(H,28,30);1-7,16,19,28H,8-15,17H2,(H,25,27);1-4,16,27H,5-14H2,(H,24,26);7-8,17,23H,2-6,9-16H2,1H3,(H,20,22);16,22H,2-15H2,1H3,(H,19,21);4*1H/b;;;;;8-7+;;;;;
InChIKeyHNMQRBWGIBLSGP-QFQGCDLXSA-N
XLogP20.40
TPSA760.06 Ų
H-Bond Donors14
H-Bond Acceptors43
Rotatable Bonds53
Heavy Atoms227
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003415.80
LogP ≤ 520.40
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1043

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride?
The IUPAC name of 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride (CID 162182654) is 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride.
What is the SMILES notation for 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride?
The canonical SMILES for 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride is CCCCCC/C=C/C1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCCCCOC1CCN(S(=O)(=O)C2(C(=O)NO)CCOCC2)CC1.CCCCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.CCc1ccc(-c2ccc(C3CCN(S(=O)(=O)C4(C(=O)NO)CCOCC4)CC3)nc2)cc1.Cl.Cl.Cl.Cl.O=C(NO)C1(S(=O)(=O)N2CCC(COCc3ccc(OC(F)(F)F)cc3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(-c4ccc(C(F)(F)F)cc4)cn3)CC2)CCOCC1.O=C(NO)C1(S(=O)(=O)N2CCC(c3ccc(OCc4ccccc4)cn3)CC2)CCOCC1.
What is the InChIKey of 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride?
The InChIKey is HNMQRBWGIBLSGP-QFQGCDLXSA-N. The full InChI is InChI=1S/C26H35N3O5S.C24H31N3O5S.C23H26F3N3O5S.C23H29N3O6S.C20H27F3N2O7S.C19H34N2O5S.C18H34N2O6S.4ClH/c1-2-3-4-20-5-7-21(8-6-20)23-9-10-24(27-19-23)22-11-15-29(16-12-22)35(32,33)26(25(30)28-31)13-17-34-18-14-26;1-2-18-3-5-19(6-4-18)21-7-8-22(25-17-21)20-9-13-27(14-10-20)33(30,31)24(23(28)26-29)11-15-32-16-12-24;24-23(25,26)19-4-1-16(2-5-19)18-3-6-20(27-15-18)17-7-11-29(12-8-17)35(32,33)22(21(30)28-31)9-13-34-14-10-22;27-22(25-28)23(10-14-31-15-11-23)33(29,30)26-12-8-19(9-13-26)21-7-6-20(16-24-21)32-17-18-4-2-1-3-5-18;21-20(22,23)32-17-3-1-15(2-4-17)13-31-14-16-5-9-25(10-6-16)33(28,29)19(18(26)24-27)7-11-30-12-8-19;1-2-3-4-5-6-7-8-17-9-13-21(14-10-17)27(24,25)19(18(22)20-23)11-15-26-16-12-19;1-2-3-4-5-6-13-26-16-7-11-20(12-8-16)27(23,24)18(17(21)19-22)9-14-25-15-10-18;;;;/h5-10,19,22,31H,2-4,11-18H2,1H3,(H,28,30);3-8,17,20,29H,2,9-16H2,1H3,(H,26,28);1-6,15,17,31H,7-14H2,(H,28,30);1-7,16,19,28H,8-15,17H2,(H,25,27);1-4,16,27H,5-14H2,(H,24,26);7-8,17,23H,2-6,9-16H2,1H3,(H,20,22);16,22H,2-15H2,1H3,(H,19,21);4*1H/b;;;;;8-7+;;;;;.
What are the key properties of 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride?
4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride has a molecular weight of 3415.80 g/mol, XLogP of 20.40, 53 rotatable bonds, 14 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[5-(4-butylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-[4-[5-(4-ethylphenyl)-2-pyridinyl]piperidin-1-yl]sulfonyl-N-hydroxyoxane-4-carboxamide;4-(4-heptoxypiperidin-1-yl)sulfonyl-N-hydroxyoxane-4-carboxamide;N-hydroxy-4-[4-[(E)-oct-1-enyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-(5-phenylmethoxy-2-pyridinyl)piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[[4-(trifluoromethoxy)phenyl]methoxymethyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-[4-(trifluoromethyl)phenyl]-2-pyridinyl]piperidin-1-yl]sulfonyloxane-4-carboxamide;tetrahydrochloride is sourced from PubChem (CID 162182654), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).